Lai Ling Sharon Chan

1 Patent

• US123197332025

  THREONINE166 and SERINE189 of Rubicon Run Domain as LRRK2 Kinase Inhibition Target Sites

  SINGAPORE HEALTH SERVICES PTE Ltd

  0 cites